Skip to main content
HomeDrug Comparisons
Drug bottle and Pill

Compare Farxiga vs. Wegovy

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Dapagliflozin (Farxiga) and semaglutide (Wegovy) are both medications used to help manage conditions related to diabetes and heart health, but they belong to different medication classes and have distinct uses. Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor taken orally once a day, primarily used to lower blood sugar in people with Type 2 diabetes and to reduce the risk of heart failure and kidney problems. It is available in both brand-name and generic forms. Common side effects include urinary tract infections, yeast infections, and increased urination. Semaglutide, on the other hand, is a glucagon-like peptide-1 (GLP-1) receptor agonist administered as a weekly injection, mainly used for long-term weight management and to lower the risk of heart problems in people with a larger body size. It is not available in a generic form. Other forms of semaglutide (Ozempic, Rybelsus) are used to treat Type 2 diabetes. Common side effects include nausea, diarrhea, and stomach pain. While both medications can interact with other diabetes treatments, dapagliflozin has specific interactions with diuretics and lithium.

  • Farxiga (dapagliflozin)
    Wegovy (semaglutide)
  • Farxiga (dapagliflozin)
    Wegovy (semaglutide)

  • Summary of Farxiga vs. Wegovy

    Summary for SGLT2 inhibitor
    Prescription only

    Farxiga, the brand name for dapagliflozin, is used together with a nutritious diet and exercise plan to lower blood sugar levels in people 10 years and older with Type 2 diabetes. It can also help lower the risk of serious complications, hospitalization, and death in certain adults with heart failure or chronic kidney disease (CKD). Farxiga (dapagliflozin) belongs to the drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors. It's taken by mouth once a day. Some side effects include yeast infections, urinating more often, and weight loss.

    Summary for GLP-1 agonist
    Prescription only

    Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It comes in prefilled pens you use to inject the medication under the skin once a week. Wegovy (semaglutide) also comes as tablets that are swallowed once a day. This medication is approved for weight loss in some people. It can help lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The pens are also approved for certain adults with a liver problem called metabolic dysfunction-associated steatohepatitis (MASH). The medication works best when taken with a lower-calorie diet and regular exercise. Side effects include nausea, diarrhea, and stomach pain.

  • Indications of Farxiga vs. Wegovy

    Indications for
    •Type 2 diabetes (in addition to diet and exercise) in people age 10 and over
    •Lowering the risk of hospitalization for heart failure in adults with Type 2 diabetes and heart disease
    •Lowering the risk of hospitalization and death due to heart problems in people with heart failure
    •Lowering the risk of worsening kidney problems, hospitalization for heart failure, and death due to heart problems in adults with chronic kidney disease (CKD)
    Indications for

    Injectable pens:

    •

    Weight loss and long-term weight management in:

    •People ages 12 years and older who are considered obese
    •Adults considered overweight with at least one weight-related condition (e.g., high blood pressure, Type 2 diabetes, high cholesterol)
    •

    Lowering the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease

    •

    Metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate-to-advanced liver scarring, but not cirrhosis

    Tablets:

    •Weight loss and long-term weight management in adults who are considered obese or overweight with at least one weight-related condition
    •Lowering the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease

  • Pros and Cons of Farxiga vs. Wegovy

    Pros and Const for SGLT2 inhibitor
    Pros
    •Taken only once daily
    •Low risk of causing low blood sugar when taken by itself
    •Can take with other diabetes medications
    Cons
    •Raises risk of yeast infections and urinary tract infections (UTIs)
    •Not available as a liquid
    •Not recommended during the second and third trimesters of pregnancy
    Pros and Const for GLP-1 agonist
    Pros
    •Available as once-weekly injectable pens and as once-daily pills
    •Injectable pens approved for weight loss in children ages 12 years and older considered obese
    Cons
    •Can cause stomach pain, nausea, and diarrhea
    •Can't take with other semaglutide products (Ozempic, Rybelsus) or with other GLP-1 agonists

  • Common Side Effects of Farxiga vs. Wegovy

    Common Side Effects for
    •Vaginal yeast infection in females (7-8%)
    •Nose and throat infection (6-7%)
    •Urinary tract infection (UTI, 4-6%)
    Common Side Effects for
    •Nausea (44%)
    •Diarrhea (30%)
    •Vomiting (24%)
    •Constipation (24%)
    •Stomach pain (20%)
    •Headache (14%)
    •Tiredness (11%)

  • Warnings of Farxiga vs. Wegovy

    Common Side Effects for
    •Ketoacidosis
    •Low fluids in the body (leading to low blood pressure or dehydration)
    •Genital and urinary tract infections
    •Low blood sugar (hypoglycemia) when used with other diabetes medications
    Common Side Effects for
    •Possible risk for thyroid cancer
    •Inflammation of the pancreas (pancreatitis)
    •Gallbladder problems
    •Low blood sugar
    •Kidney damage
    •Allergic reactions
    •Eye problems in people with Type 2 diabetes (diabetic retinopathy)
    •Faster heart rate
    •Possible risk of self-harm
    •Lung problems during general anesthesia or deep sedation

  • Prices with our coupons for Farxiga vs. Wegovy

    Learn more about Farxiga
    Learn more about Wegovy

Compare other Kidney Disease and Weight loss drugs

Brenzavvy vs FarxigaEntresto vs FarxigaFarxiga vs ActosFarxiga vs AfrezzaFarxiga vs GlucotrolFarxiga vs GlyburideFarxiga vs InvokanaFarxiga vs JardianceFarxiga vs KerendiaFarxiga vs MetforminFarxiga vs OzempicFarxiga vs RybelsusFarxiga vs WegovyInpefa vs FarxigaJanuvia vs FarxigaSteglatro vs FarxigaActos vs BaqsimiActos vs InvokanaGlucotrol vs ActosGlyburide vs ActosHumalog vs ActosHuman Insulin vs ActosInvokamet vs ActosJanumet vs ActosJanuvia vs ActosJardiance vs ActosLantus vs ActosLevemir vs ActosMetaglip vs ActosMetformin vs Actos
View More

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.